Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII.

Recio-López, Patricia; Valladolid-Acebes, Ismael; Hadwiger, Philipp; Hossbach, Markus; Krampert, Monika; Prata, Carla; Berggren, Per-Olof; Juntti-Berggren, Lisa

Recio-López, Patricia; Valladolid-Acebes, Ismael; Hadwiger, Philipp; Hossbach, Markus; Krampert, Monika; Prata, Carla; Berggren, Per-Olof; Juntti-Berggren, Lisa.

Afiliação

Recio-López P; The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Valladolid-Acebes I; The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Hadwiger P; Axolabs GmbH, Kulmbach, Germany.
Hossbach M; Axolabs GmbH, Kulmbach, Germany.
Krampert M; Axolabs GmbH, Kulmbach, Germany.
Prata C; Axolabs GmbH, Kulmbach, Germany.
Berggren PO; The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Juntti-Berggren L; The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.

Biofactors ; 49(1): 153-172, 2023 Jan.

Article em En | MEDLINE | ID: mdl-36039858

Assuntos

Diabetes Mellitus Tipo 2; Síndrome Metabólica; Camundongos; Animais; Apolipoproteína C-III/genética; Apolipoproteína C-III/metabolismo; Apolipoproteína C-III/farmacologia; RNA Interferente Pequeno; Obesidade

Palavras-chave

apolipoprotein CIII; diabetes; glucose homeostasis; insulin sensitivity; liver; metabolic syndrome; siRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome Metabólica / Diabetes Mellitus Tipo 2 Tipo de estudo: Guideline Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google